Meng Huang

Meng Huang has extensive experience in drug metabolism and pharmacokinetics (DMPK), primarily focusing on small molecule drugs for viral infections and liver diseases at Enanta Pharmaceuticals since October 2016, holding roles from Scientist to Principal Investigator. Previous positions include Research Associate and Postdoctoral Researcher at the University of Pennsylvania, where work involved the metabolism of environmental chemicals related to the Deepwater Horizon oil spill and pyrogenic polycyclic aromatic hydrocarbons. Meng also contributed as a Research Assistant at the National University of Singapore and participated in a joint research program at Queen's University Belfast. An early career as a Pharmacist at The First Affiliated Hospital, Xi'an Jiaotong University, included investigating the impact of ganciclovir on cyclosporin A pharmacokinetics in kidney transplant patients. Educational credentials include a Ph.D. in DMPK from the National University of Singapore and an M.S. in Medicinal Chemistry from Peking Union Medical College.